UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063702
Receipt number R000072899
Scientific Title Comparison of durability and running economy between running shoes with advanced footwear technology
Date of disclosure of the study information 2026/11/19
Last modified on 2026/11/19 20:45:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of durability and running economy between running shoes with advanced footwear technology

Acronym

Comparison of durability and running economy between running shoes with advanced footwear technology

Scientific Title

Comparison of durability and running economy between running shoes with advanced footwear technology

Scientific Title:Acronym

Comparison of durability and running economy between running shoes with advanced footwear technology

Region

Japan


Condition

Condition

Healthy Subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the efficacy of different advanced footwear technology shoes in attenuating the degradation of running economy during prolonged running.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Oxygen uptake drift rate

Key secondary outcomes

Oxygen uptake
Energy expenditure
Energy expenditure drift rate
Heart rate
Rating of perceived exertion
Perceived comfort


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Wearing test shoes

Interventions/Control_2

Wearing control shoes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

49 years-old >

Gender

Male

Key inclusion criteria

Healthy males aged 18 to 48 years at the time of informed consent, with no history of serious illness.
Individuals with a personal best time of under 3 hours and 30 minutes in a full marathon completed in or after January 2024.
Individuals who run regularly at least 3 times a week.

Key exclusion criteria

Individuals currently undergoing treatment for any disease, or with a history of serious diseases requiring medication (e.g., cardiovascular, respiratory, or metabolic diseases).
Individuals with orthopedic complaints (e.g., joint pain, ligamentitis) or a history of trauma that would interfere with prolonged treadmill running.
Individuals who have sustained an injury within the past two months that interferes with running.
Individuals who routinely take medications or supplements that affect thermoregulation, cardiovascular function, or metabolism.
Current smokers.
Individuals with skin diseases or allergies that interfere with the wearing of measurement devices (e.g., respiratory gas analysis masks, heart rate monitors).
Others judged unsuitable for participation in this study by the principal investigator due to health conditions, safety concerns, or other reasons.
Employees of sports apparel and footwear-related companies (e.g., sporting goods manufacturers, agencies) or their family members.
Others judged by the principal investigator to have a significant conflict of interest regarding this study (and its funding source).


Target sample size

12


Research contact person

Name of lead principal investigator

1st name Fuminori
Middle name
Last name Takayama

Organization

EUPHORIA Co., Ltd.

Division name

Corporate Business Division

Zip code

102-0083

Address

10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan

TEL

03-6388-9260

Email

fuminori.takayama@eu-phoria.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Urushizawa

Organization

EUPHORIA Co., Ltd.

Division name

Corporate Business Division

Zip code

102-0083

Address

10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan

TEL

03-6388-9260

Homepage URL


Email

yuki.urushizawa@eu-phoria.jp


Sponsor or person

Institute

EUPHORIA Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Goldwin Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 19 Day

Date of IRB

2026 Year 11 Month 19 Day

Anticipated trial start date

2026 Year 11 Month 20 Day

Last follow-up date

2027 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 19 Day

Last modified on

2026 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072899